Skip to main content
. 2021 Feb 17;160(7):2588–2590.e7. doi: 10.1053/j.gastro.2021.02.028

Figure 1.

Figure 1

Forest plots showing associations between PPI or famotidine use and severe disease and mortality. (A) Famotidine and severe disease: analysis of studies reporting data as OR. (B) Famotidine and severe disease: analysis of studies reporting data as HR. (C) PPI and severe disease: analysis of studies reporting data as OR. (D) PPI and severe disease: analysis of studies reporting data as HR. (E) Famotidine and mortality in patients with COVID-19. (F) PPI and mortality in patients with COVID-19.